Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for Removal of Close Control for Ovestin (oestriol), browse documents here.


FACSIMILE

To All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers PHARMAC Oestriol cream and pessaries– removal of pharmacist endorsed Close Control 27 October 2011 2

From Subject

Date Pages

Dear Pharmacist / Wholesaler Due to stock shortages, PHARMAC implemented monthly Close Control with pharmacist annotation on oestriol cream 1 mg per g with applicator and pessaries 500 µg from 8 March 2011. The stock situation has been resolved and PHARMAC is now providing notice that from Friday 28 October 2011, all new prescriptions for oestriol cream and pessaries (Ovestin) are to be dispensed stat (3 monthly) unless endorsed by a prescriber that dispensing should be more frequent via the Close Control rule. Oestriol cream and pessaries (Ovestin) are back in the market and we have confirmed continuation of supply from the manufacturer. Please note that if a prescription has eligible/subsidised repeats for oestriol cream or pessaries first dispensed Close Control monthly between 8 March 2011 and 27 October 2011, the repeats can either be (at the discretion of the pharmacist and stock availability): o o completed Close Control monthly, or dispensed stat where appropriate.

Pharmacists will need to annotate any prescriptions and repeats that continue to be dispensed Close Control monthly for audit purposes. Instructions have been included on how to amend dispensing software below. If you have any questions regarding the above, please contact PHARMAC on 0800 66 00 50 (9:00am – 5:00pm, Monday to Friday). Yours sincerely

Rebecca Bloor Schedule Analyst

This facsimile message contains information that is confidential and which may be subject to legal privilege. If you are not the intended recipient, you must not peruse, use, disseminate, distribute or copy this message. If you have received this message in error, please notify us immediately by facsimile or telephone (call us collect) and return the original message to us by mail. Thank you.

A462472 qA21349


Toniq Users

How to terminate ‘short supply’ Close Control monthly rule in Toniq From the Dispensary program’s main menu. 1. Prescriptions  F7 Med 767441<Enter> OVESTIN crm 1 mg per g with applicator Select first pcode and set End date, then 767468<Enter> OVESTIN pessaries 500 µg the other. F11 Page 2 F11 Page 3 Check Limited stock close control – parameters: If the Start date is blank, NO ACTION is required..

IF Start date is NOT blank >>>>> Set End date to 28/10/11>>>>>> . F11 Page1 F12 Accept Details

Lots users

Dispense these medicines as ‘Stat supply’ unless the prescriber has annotated the script with Close Control. i.e. Only say yes to the ‘Close Control’ prompt if the script is annotated ‘Close Control’ by the prescriber. There is no need to change anything in the stockcards.

A462472qA21349

2 of 2

Metadata

Title

Removal of Close Control for Ovestin (oestriol)

Abstract

FACSIMILE To All New Zealand Pharmacies, IPA Pharmacy Facilitators and Wholesalers PHARMAC Oestriol cream and pessaries– removal of pharmacist endorsed Close Control 27 October 2011 2 From Subject Date Pages Dear Pharmacist / Wholesaler Due to stock shortages, PHARMAC implemented…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.